Quantum dots-based double-color imaging of HER2 positive breast cancer invasion

Biochemical and Biophysical Research Communications

Volumn 409, Issue 3, 2011, Pages 577-582

  Liu, Xiu Li ^a,b   Peng, Chun Wei ^a,b   Chen, Chuang ^a,b   Yang, Xue Qin ^a,b   Hu, Ming Bai ^a,b   Xia, He Shun ^c   Liu, Shao Ping ^a,b   Pang, Dai Wen ^d   Li, Yan ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center   (China)

^c HUBEI CANCER HOSPITAL   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

Breast cancer invasion; HER2; Quantum dots; Type IV collagen

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; QUANTUM DOT;

ARTICLE; BLOOD VESSEL; BREAST CANCER; BREAST TUMOR; CANCER CELL; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MOLECULAR IMAGING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THEORY;

BLOOD VESSELS; BREAST NEOPLASMS; COLLAGEN TYPE IV; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; QUANTUM DOTS; RECEPTOR, ERBB-2; TISSUE EMBEDDING;

EID: 79958209681     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.052     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J.Q., et al. Cancer Statistics Ca-a Cancer. Journal for Clinicians 2010, 60:277-300.
2. Chen C., Xia H.S., Gong Y.P., et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials 2010, 31:8818-8825.
3. Mahmoud W., Sukhanova A., Oleinikov V., et al. Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection. Proteomics 2010, 10:700-716.
4. Friedl P., Wolf K. Plasticity of cell migration: A multiscale tuning model. J. Cell. Biol. 2010, 188:11-19.
5. Decock J., Hendrickx W., Wildiers H., et al. Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status Her2/neu expression and other clinicopathological variables. Clin. Exp. Metastas. 2005, 22:495-502.
6. Nakopoulou L., Tsirmpa I., Alexandrou P., et al. MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival. Breast Cancer Res. Tr. 2003, 77:145-155.
7. Duffy M.J., McGowan P.M., Gallagher W.M. Cancer invasion and metastasis: changing views. J. Pathol. 2008, 214:283-293.
8. Pommier S.J., Quan G.G., Christante D., et al. Characterizing the HER2/neu status and metastatic potential of Breast cancer stem/progenitor cells. Ann. Surg. Oncol. 2010, 17:613-623.
9. Korkaya H., Paulson A., Iovino F., et al. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 2008, 27:6120-6130.
10. Jezierska A., Motyl T. Matrix Metalloproteinase-2 involvement in breast cancer progression: A mini-review. Medical Science Monitor 2009, 15:RA32-RA40.
11. Pellikainen J.M., Ropponen K.M., Kataja V.V., et al. Expression of matrix metalloproteinase MMP-2 and MMP-9 in breast cancer with special reference to activator protein-2 HER2 and prognosis. Clin. Cancer Res. 2004, 10:7621-7628.
12. Pugliese M., Stempel M., Patil S., et al. The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. Am. J. Surg. 2010, 200:368-373.
13. Huang D.H., Peng X.H., Su L., et al. Comparison and optimization of multiplexed quantum dot-based immunohistofluorescence. Nano Res. 2010, 3:61-68.
14. Pelley J.L., Daar A.S., Saner M.A. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol. Sci. 2009, 112:276-296.
15. Resch-Genger U., Grabolle M., Cavaliere-Jaricot S., et al. Quantum dots versus organic dyes as fluorescent labels. Nat. Methods 2008, 5:763-775.
16. Jin T., Tiwari D.K., Tanaka S., et al. Antibody-ProteinA conjugated quantum dots for multiplexed imaging of surface receptors in living cells. Mol. Biosyst. 2010, 6:2325-2331.
17. Zhang H., Yee D., Wang C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomed. 2008, 3:83-91.
18. Smith A.M., Nie S.M. Next-generation quantum dots. Nat. Biotechnol. 2009, 27:732-733.
19. Chen L.D., Liu J., Yu X.F., et al. The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. Biomaterials 2008, 29:4170-4176.
20. Chen C., Peng J., Xia H.S., et al. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials 2009, 30:2912-2918.
21. Chen C., Peng J., Xia H.S., et al. Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity. Nanotechnology 2010, 21.
22. Peng C.W., Liu X.L., Chen C., et al. Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. Biomaterials 2011, 32:2907-2917.
23. Peng C.W., Liu X.L., Liu X., et al. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. Journal of Translational Medicine 2010, 8:101.
24. Leong A.S.Y., Leong T.Y.M. Newer developments in immunohistology. J. Clin. Pathol. 2006, 59:1117-1126.
25. Gancberg D., Jarvinen T., di Leo A., et al. Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing. Breast Cancer Res. Tr. 2002, 74:113-120.
26. Baba Y., Iyama K.I., Ikeda K., et al. The expression of type IV collagen alpha 6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2008, 15:555-565.
27. True L.D., Gao X.H. Quantum dots for molecular pathology - Their time has arrived. J. Mol. Diagn. 2007, 9:7-11.
28. Liu J., Lau S.K., Varma V.A., et al. Molecular Mapping of Tumor Heterogeneity on Clinical Tissue Specimens with Multiplexed Quantum Dots. ACS Nano 2010, 4:2755-2765.
29. Xing Y., Chaudry Q., Shen C., et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat. Protoc. 2007, 2:1152-1165.
30. Jang J.Y., Jeon Y.K., Kim C.W. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 2010, 10.
31. Bao W., Fu H.J., Jia L.T., et al. HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion. Arch. Biochem. Biophys. 2010, 499:49-55.
32. Eceles S.A. The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis. J. Mammary Gland Biol. Neoplasia 2001, 6:393-406.
33. Arora P., Cuevas B.D., Russo A., et al. Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene 2008, 27:4434-4445.
34. Lang J.E., Mosalpuria K., Cristofanilli M., et al. HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res. Tr. 2009, 113:501-507.
35. Zemzoum I., Kates R.E., Ross J.S., et al. Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer. J. Clin. Oncol. 2003, 21:1022-1028.
36. Liao N., Zhang G.C., Liu Y.H., et al. HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component. Pathol. Res. Pract. 2011, 207:1-7.
37. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell 2011, 144:646-674.
38. Geiger T.R., Peeper D.S. Metastasis mechanisms. Biochim. Biophys. Acta-Reviews on Cancer 2009, 1796:293-308.
39. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
40. Menard S., Balsari A., Tagliabue E., et al. prognosis and response to therapy of breast carcinomas according to HER2 score. Ann. Oncol. 2008, 19:1706-1712.
41. Talmadge J.E., Fidler I.J. AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective. Cancer Res. 2010, 70:5649-5669.